These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2044219)
1. Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies. Grau GE; Vesin C; De Groote D; Delacroix D; Gysler C; Piguet PF; Lambert PH Clin Exp Immunol; 1991 Jun; 84(3):411-4. PubMed ID: 2044219 [TBL] [Abstract][Full Text] [Related]
2. Low susceptibility of NC/Nga mice to tumor necrosis factor-alpha-mediated lethality and hepatocellular damage with D-galactosamine sensitization. Koide N; Morikawa A; Naiki Y; Tumurkhuu G; Yoshida T; Ikeda H; Yokochi T Clin Immunol; 2009 Feb; 130(2):225-32. PubMed ID: 18945641 [TBL] [Abstract][Full Text] [Related]
3. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha). McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416 [TBL] [Abstract][Full Text] [Related]
4. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality. Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of monoclonal antibodies against recombinant human tumor necrosis factor alpha. Li Y; Zhao WW; Shen BF; Sun YX; Wang WX Chin J Biotechnol; 1991; 7(2):121-6. PubMed ID: 1806022 [TBL] [Abstract][Full Text] [Related]
6. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Siegel SA; Shealy DJ; Nakada MT; Le J; Woulfe DS; Probert L; Kollias G; Ghrayeb J; Vilcek J; Daddona PE Cytokine; 1995 Jan; 7(1):15-25. PubMed ID: 7538333 [TBL] [Abstract][Full Text] [Related]
7. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody. Corti A; Bagnasco L; Cassani G Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695 [TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent enhanced lethality with combined administration of actinomycin D and tumor necrosis factor in mice. Buckley NJ; Walther PJ; Das AK; Poulton SH J Biol Response Mod; 1989 Jun; 8(3):287-96. PubMed ID: 2746299 [TBL] [Abstract][Full Text] [Related]
9. Involvement of IFN-gamma in Bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality. Cauwels A; Brouckaert P; Grooten J; Huang S; Aguet M; Fiers W J Immunol; 1995 Mar; 154(6):2753-63. PubMed ID: 7876546 [TBL] [Abstract][Full Text] [Related]
13. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice? Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1. Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice. Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427 [TBL] [Abstract][Full Text] [Related]
16. Selective species specificity of tumor necrosis factor for toxicity in the mouse. Brouckaert P; Libert C; Everaerdt B; Fiers W Lymphokine Cytokine Res; 1992 Aug; 11(4):193-6. PubMed ID: 1420597 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064 [TBL] [Abstract][Full Text] [Related]
19. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia. Barton MH; Bruce EH; Moore JN; Norton N; Anders B; Morris DD Am J Vet Res; 1998 Jun; 59(6):792-7. PubMed ID: 9622754 [TBL] [Abstract][Full Text] [Related]
20. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo. Yan Z; Zhao N; Wang Z; Li B; Bao C; Shi J; Han W; Zhang Y Cytotherapy; 2006; 8(4):415-23. PubMed ID: 16923618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]